Clinical Trials Logo
  1. Home
  2. Sepsis, Severe
  3. NCT05442710

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy — ReActiF-ICE  

Sepsis, Severe Clinical Trial

Official title:
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy

Clinical Trial Summary

Evaluation of a novel therapy approach for severe sepsis patients. Subjects randomized into the treatment arm receive treatment with an immune cell perfusion system on top of standard care. This may contribute to the improvement of the impaired organ function of septic shock patients by assisting the impaired immune system (immune competence enhancement = ARTICE)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05442710
Study type Interventional
Source Artcline GmbH
Contact Jens Altrichter, MD
Phone +49 381-440-703
Email jens.altrichter@artcline.de
Status Recruiting
Phase Phase 2
Start date July 24, 2022
Completion date May 31, 2025
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT04134624 - EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock N/A
Withdrawn NCT04821414 - Effects of IL-1β and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children
Recruiting NCT05357339 - Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock N/A
Recruiting NCT06178822 - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Completed NCT04833621 - Is NMES Treatment in Sepsis/ Septic Shock Patients Protective in Development of ICU-AW? N/A
Not yet recruiting NCT04105400 - Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
Completed NCT04459572 - As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR N/A
Completed NCT04508296 - The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality N/A
Recruiting NCT03685214 - Comparison of Balanced Crystalloids and Normal Saline in Septic Patients N/A
Not yet recruiting NCT04850456 - Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
Completed NCT04747795 - Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments Phase 3
Terminated NCT03821038 - Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients Phase 2
Completed NCT05246969 - Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
Completed NCT05467605 - Effect of Probiotics on Cytokines in Sepsis in Children N/A
Completed NCT03974386 - Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock N/A
Recruiting NCT04203979 - Sepsis: From Syndrome to Personalized Care
Not yet recruiting NCT03367026 - Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine N/A
Recruiting NCT03244293 - Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis